Back to peptide library

Skin quality and recovery blend

GLOW Stack

A three-component recovery and tissue-quality profile built around GHK-Cu, BPC-157, and TB-500.

3 peptide detailsGHK-Cu collagen supportBPC localized recoveryTB-500 remodeling support

Overview

What is the GLOW stack?

The GLOW stack adapts the tissue-support and regeneration information into three IPS-aligned peptides: GHK-Cu for collagen, skin integrity, hair or scalp support, and soft-tissue quality; BPC-157 for localized tissue and gut-related recovery context; and TB-500 for cell mobility, tissue remodeling, and broader recovery capacity.

Common program goals

  • Review skin quality, collagen support, and soft-tissue resilience
  • Review recovery, connective-tissue, tendon, ligament, or joint goals
  • Coordinate with training, rehab, nutrition, sleep, and medical screening
  • Separate aesthetic goals from injury, wound, or dermatology concerns
  • Track tolerance, response, function, and who it may fit over time

Peptide details

GLOW stack peptide profile.

Skin quality

GHK-Cu

A copper peptide used as part of clinician-guided planning for collagen support, elastin support, antioxidant defense, tissue signaling, skin integrity, hair or scalp support, and soft-tissue quality.

Localized recovery

BPC-157

Used as part of clinician-guided planning for localized tissue recovery, tendon and ligament goals, connective tissue, soft tissue, joints, and gut-related recovery context.

Remodeling support

TB-500

Used as part of clinician-guided planning for cell mobility, tissue remodeling, systemic recovery support, mobility, and active-lifestyle recovery capacity.

How It Works

Three peptides, complementary recovery lanes.

IPS frames this stack as a coordinated tissue-quality and recovery option, not a one-size-fits-all promise. The goal is to determine whether this blend fits the patient’s recovery needs, safety profile, and broader clinical context.

Collagen and skin quality

GHK-Cu is the most skin-quality focused component and is used for collagen, skin integrity, hair or scalp support, and soft-tissue quality.

Localized tissue support

BPC-157 is commonly used as part of clinician-guided planning for tendons, ligaments, joints, soft tissue, connective tissue, and gut-related recovery context.

Systemic remodeling support

TB-500 is commonly used as part of clinician-guided planning for cell mobility, tissue remodeling, mobility support, and whole-body recovery capacity.

Clinical foundation

This belongs inside a care plan that considers diagnosis, rehab, training load, nutrition, sleep, medications, and follow-up.

Process

How GLOW stack care works at IPS.

01

Goal Review

Review skin, hair or scalp, recovery, connective-tissue, training, procedure, and symptom goals.

02

Medical Screening

Clarify medications, health history, active diagnoses, skin or wound concerns, and whether direct medical care is needed.

03

Component Selection

If appropriate, your clinician reviews whether this blend fits and what should be monitored.

04

Follow-Up

Follow-up tracks tolerance, recovery markers, skin or tissue goals, function, and whether the plan should change.

Safety & candidacy

GLOW stack decisions require clinical review.

IPS reviews medical history, cancer history, active skin or wound concerns, infection concerns, current medications, pregnancy-related factors where applicable, procedure planning, and whether the goal is appropriate for peptide review.

Common effectsInjection-site irritation, fatigue, headache, digestive changes, or temporary symptom shifts may occur.
Care firstAcute injuries, infection signs, severe pain, wound issues, or post-procedure complications require appropriate medical care.
Medication reviewMedications, immune-modulating drugs, anticoagulants, dermatology treatments, and supplements should be disclosed.
No guaranteesResults vary and this blend is not intended to diagnose, treat, cure, or prevent disease.

Questions

Frequently asked.

Why combine these three peptides?

GHK-Cu supports collagen and tissue-quality information, BPC-157 supports localized recovery context, and TB-500 supports remodeling and broader recovery-capacity information.

Is this only for skin goals?

No. It may be framed around skin quality, soft-tissue quality, recovery, connective tissue, and active-lifestyle goals, but candidacy requires clinician review.

Can this replace medical care or rehab?

No. Injuries, wounds, infections, post-surgical concerns, skin lesions, and persistent pain should be evaluated and treated through appropriate medical care.

Why IPS is different

Not gray market. Not research-only. Not direct-to-consumer peptide kits.

Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.

RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS

Products marketed online

  • May be labeled research use only
  • May be labeled not for human consumption
  • May be marketed as laboratory chemicals
  • May not include patient-specific documentation
  • May not involve provider review

The IPS approach

  • Consultation before recommendation
  • Provider review
  • Personalized recommendations
  • Medical oversight
  • Ongoing guidance and support
Important distinction

A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.

Annual Membership

Wholesale-Style Member Pricing

12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.

12-month membership requiredMember pricing reviewed during consultClinical review before any plan
Ask About Membership Pricing

Contact

Ask IPS about GLOW stack eligibility.

Send your details and IPS can follow up about consultation scheduling and next steps.

Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require qualified clinical care.